The effectiveness and safety of exoskeletons as assistive and rehabilitation devices in the treatment of neurologic gait disorders in patients with spinal cord injury: a …

…, M Moisi, A Mayadev, KT Pagarigan… - Global spine …, 2016 - journals.sagepub.com
Study Design Systematic review. Clinical Questions (1) When used as an assistive device,
do wearable exoskeletons improve lower extremity function or gait compared with knee-ankle-…

[HTML][HTML] Use of the IL‐6R antagonist tocilizumab in hospitalized COVID‐19 patients

…, J Frisvold, S Megrath, K Pagarigan… - Journal of internal …, 2021 - ncbi.nlm.nih.gov
Methods This retrospective cohort study included 42 adults (≥ 18 years old) hospitalized for
COVID‐19 and treated with tocilizumab at Swedish Medical Center (Seattle, USA) between …

Change in function, pain, and quality of life following structured nonoperative treatment in patients with degenerative cervical myelopathy: a systematic review

…, AH Dembek, KT Pagarigan… - Global spine …, 2017 - journals.sagepub.com
Study Design: Systematic review. Objectives: The objective of this study was to conduct a
systematic review to determine (1) change in function, pain, and quality of life following …

Catastrophic cervical spine injuries in contact sports

…, K Mazda, P Davies, KT Pagarigan… - Global spine …, 2016 - journals.sagepub.com
Study Design Systematic review. Objectives To determine the incidence of catastrophic
cervical spine injuries (CCSIs) among elite athletes participating in contact team sports and …

Return to play in athletes receiving cervical surgery: a systematic review

RW Molinari, K Pagarigan, JR Dettori… - Global spine …, 2016 - journals.sagepub.com
Study Design Systematic review. Clinical Questions Among athletes who undergo surgery
of the cervical spine, (1) What proportion return to play (RTP) after their cervical surgery? (2) …

[HTML][HTML] Drosophila PRL-1 Is a Growth Inhibitor That Counteracts the Function of the Src Oncogene

KT Pagarigan, BW Bunn, J Goodchild, TK Rahe… - PloS one, 2013 - journals.plos.org
Phosphatase of Regenerating Liver (PRL) family members have emerged as molecular
markers that significantly correlate to the ability of many cancers to metastasize. However, …

The Evolution of Burden of Novel Cell Therapy Trials on Research Operations

N Bailey, T Tsomo, K Pagarigan, E Lackey… - … and Cellular Therapy, 2024 - Elsevier
Introduction Scientific challenges of cell therapies are frequently published and discussed,
but the operational burden on research operations is not well documented. We reviewed …

[PDF][PDF] Functional neuroimaging for primary degenerative dementia or mild cognitive impairment

…, H Holmer, A Skelly, K Pagarigan… - … , WA: Washington State …, 2014 - hca.wa.gov
Dementia is a condition in which mental capabilities have declined to the point that that it
interferes with the ability to function on a daily basis. Dementia severity can range from mild to …

[PDF][PDF] Cardiac Stents (Re-Review)

AC Skelly, RE Hashimoto, ED Brodt, K Pagarigan… - 2015 - hca.wa.gov
Coronary artery disease (CAD), also referred to as coronary heart disease (CHD) or ischemic
heart disease (IHD), is the single leading cause of death for both men and women in the …

[PDF][PDF] Fecal Microbiota Transplantation

R Hashimoto, AC Skelly, E Brodt, K Pagarigan… - 2016 - hca.wa.gov
Fecal microbiota transplantation (FMT) is a procedure whereby donor fecal matter is placed
into a patient’s gastrointestinal system in order to recolonize it with normal gut bacteria that …